Your browser doesn't support javascript.
loading
Thromboprophylaxis in COVID-19: Anti-FXa-the Missing Factor?
Dutt, Tina; Simcox, David; Downey, Colin; McLenaghan, Daniella; King, Charlotte; Gautam, Manish; Lane, Steven; Burhan, Hassan.
Affiliation
  • Dutt T; Liverpool University Hospitals NHS Foundation TrustLiverpool, United Kingdom.
  • Simcox D; Liverpool University Hospitals NHS Foundation TrustLiverpool, United Kingdom.
  • Downey C; Liverpool Clinical LaboratoriesLiverpool, United Kingdomand.
  • McLenaghan D; Liverpool University Hospitals NHS Foundation TrustLiverpool, United Kingdom.
  • King C; Liverpool University Hospitals NHS Foundation TrustLiverpool, United Kingdom.
  • Gautam M; Liverpool University Hospitals NHS Foundation TrustLiverpool, United Kingdom.
  • Lane S; University of LiverpoolLiverpool, United Kingdom.
  • Burhan H; Liverpool University Hospitals NHS Foundation TrustLiverpool, United Kingdom.
Am J Respir Crit Care Med ; 202(3): 455-457, 2020 08 01.
Article in En | MEDLINE | ID: mdl-32510975

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Venous Thromboembolism / Pandemics / Anticoagulants Type of study: Incidence_studies / Prognostic_studies Limits: Humans Language: En Journal: Am J Respir Crit Care Med Journal subject: TERAPIA INTENSIVA Year: 2020 Document type: Article Affiliation country: United kingdom

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Venous Thromboembolism / Pandemics / Anticoagulants Type of study: Incidence_studies / Prognostic_studies Limits: Humans Language: En Journal: Am J Respir Crit Care Med Journal subject: TERAPIA INTENSIVA Year: 2020 Document type: Article Affiliation country: United kingdom